Can personalized use of NSAIDs be a reality in the clinic?

The use of NSAIDs in rheumatology could be improved by an appropriate risk scoring system that accounts for adverse events such as bleeding and thrombosis. Such a risk score has now been developed using data from the PRECISION trial, but is this score ready to be applied in clinical practice?

Saved in:
Bibliographic Details
Published inNature reviews. Rheumatology Vol. 15; no. 7; pp. 387 - 388
Main Author Nurmohamed, Michael T
Format Journal Article
LanguageEnglish
Published United States Nature Publishing Group 01.07.2019
Subjects
Anti-Inflammatory Agents, Non-Steroidal
Drug Users
Humans
Nonsteroidal anti-inflammatory drugs
Thrombosis
Online AccessGet full text
ISSN1759-4790
1759-4804
DOI10.1038/s41584-019-0225-7

Cover

More Information
Summary:The use of NSAIDs in rheumatology could be improved by an appropriate risk scoring system that accounts for adverse events such as bleeding and thrombosis. Such a risk score has now been developed using data from the PRECISION trial, but is this score ready to be applied in clinical practice?
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:1759-4790
1759-4804
DOI:10.1038/s41584-019-0225-7